Using advanced MRI techniques to improve brachytherapy for cervical cancer treatment
Multiparametric Magnetic Resonance Imaging as a Novel Approach to Brachytherapy for Cervical Cancer
This study is looking at a new way to make cervical cancer treatment better by using special MRI scans to help doctors place radiation catheters more accurately, which could mean more effective treatment with fewer side effects for patients receiving radiation therapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10993754 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment of cervical cancer through the use of multiparametric magnetic resonance imaging (MRI) during brachytherapy. By utilizing MRI to guide the placement of brachytherapy catheters, the research aims to ensure that radiation is accurately delivered to the tumor while minimizing damage to surrounding healthy tissues. The approach seeks to improve the precision of treatment and reduce complications associated with traditional methods. Patients undergoing external beam radiation therapy (EBRT) for cervical cancer may benefit from this innovative technique.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with locally advanced cervical cancer who are undergoing brachytherapy.
Not a fit: Patients with early-stage cervical cancer or those who are not candidates for brachytherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and reduced side effects for patients with cervical cancer.
How similar studies have performed: Previous research has shown promising results with MRI-guided brachytherapy in other cancer types, indicating potential success for this novel approach in cervical cancer.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Viswanathan, Akila — Johns Hopkins University
- Study coordinator: Viswanathan, Akila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.